VMP 33631511000001109

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Deferasirox 90mg tablets
BNF code 0901030K0AAADAD
Virtual Therapeutic Moiety Deferasirox
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Deferasirox
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 90.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Deferasirox 90mg tablets (Accord-UK Ltd)
Deferasirox 90mg tablets (Amarox Ltd)
Deferasirox 90mg tablets (Consilient Health Ltd)
Deferasirox 90mg tablets (Dr Reddy's Laboratories (UK) Ltd)
Deferasirox 90mg tablets (Glenmark Pharmaceuticals Europe Ltd)
Deferasirox 90mg tablets (MSN Laboratories Europe Ltd)
Deferasirox 90mg tablets (Sandoz Ltd)
Deferasirox 90mg tablets (Teva UK Ltd)
Deferasirox 90mg tablets (Torrent Pharma (UK) Ltd)
Deferasirox 90mg tablets (Viatris UK Healthcare Ltd)
Deferasirox 90mg tablets (Zentiva Pharma UK Ltd)
Exjade 90mg tablets (Novartis Pharmaceuticals UK Ltd)
Virtual Medicinal Product Packs
Deferasirox 90mg tablets 30 tablet

dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.

Feedback